EUVIMEDEUVIMED entdecken
Open Access

MALAT1 promotes malignancy of HBV-related hepatocellular carcinoma by regulating IGF2BP3-mediated nuclear-cytoplasmic shuttling

Ze-Bang Du, Xin-Mou Wu, Tun Han, Yu-Xin Cai, Bo Qian, Yu-Shi Shen, Han-Yu Zhang, Jia-Shen Wu, Jie He, Xiao-Xuan Chen, Dong-Bei Guo, Hang-Tian Zhong und 6 weitere

International Journal of Biological Sciences · 2025

DOI: 10.7150/ijbs.112133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2025. Verfasst von Ze-Bang Du und 17 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Xiang'an Hospital of Xiamen University, National Innovatio…. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Carcinoma, Hepatocellular, Liver Neoplasms, RNA-Binding Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis B virus (HBV) X protein (HBx) plays a critical role in the progression of HBV-related hepatocellular carcinoma (HCC). Long non-coding RNAs (lncRNAs) regulate various biological processes and contribute to HCC development, with their therapeutic potential in disease progression recently gaining significant attention. However, the involvement of lncRNAs in HBx-related hepatocarcinogenesis and the underlying regulatory mechanisms remain unclear. In this study, we conducted a comprehensive analysis of multi-database sequencing data to identify metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) as an HBx-associated lncRNA and observed its upregulation in HBV-related HCC tissues and cells upon HBx expression. Additionally, high MALAT1 expression was correlated with poor prognosis and advanced HCC progression. MALAT1 overexpression significantly promoted the proliferation, migration, and invasion of HCC cells. Mechanistic investigations revealed that MALAT1 was transported to the cytoplasm and enhanced RNA stability in a N6-methyladenosine (m6A)-dependent manner through direct interaction with and recruitment of insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3). Targeting MALAT1 in vivo with antisense oligonucleotides (ASO)-MALAT1 treatment effectively suppressed the progression of xenograft tumors and orthotopic liver tumors in HBx-related HCC. Moreover, hydrodynamic-based gene delivery (HGD) was utilized to introduce anti-HBx transposon plasmids into murine hepatocytes, thereby suppressing MALAT1-m6A-mediated HBV-related hepatocarcinogenesis in HBx transgenic (HBx-Tg) mice. Overall, our findings shed novel light on the regulatory role of IGF2BP3-mediated MALAT1 nuclear-cytoplasmic shuttling and RNA stabilization via m6A modification during HCC progression. These results suggest that m6A-based MALAT1 expression serves as a novel diagnostic and prognostic biomarker for targeted epigenetic intervention in HBV-related HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Long NoncodingCarcinoma, HepatocellularLiver NeoplasmsRNA-Binding ProteinsHumansAnimalsMiceHepatitis B virusViral Regulatory and Accessory ProteinsCell Line, TumorCell ProliferationMaleTrans-ActivatorsCell MovementGene Expression Regulation, NeoplasticHep G2 CellsCytoplasmFemaleMice, Nude

Stichwörter der Autor:innen

HBV-related HCCIGF2BP3MALAT1anti-HBx transposon plasmidsm6A modificationnuclear-cytoplasmic shuttling

Substanzen

RNA, Long NoncodingMALAT1 long non-coding RNA, humanRNA-Binding ProteinsIGF2BP3 protein, humanViral Regulatory and Accessory Proteinshepatitis B virus X proteinTrans-Activators

Autor:innen und Institutionen

  • State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, Xiang'an Hospital of Xiamen University, National Innovation Platform for Industry-Education Integration in Vaccine Research, Sch…
  • Department of Preventive Medicine, School of Public Health, Chengdu Medical College, Chengdu 610500, China.
  • Department of Hepatobiliary Surgery, Cancer Research Center, Xiang'an Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian 361102, China.

Zitieren

APA

Du, Z. B., Wu, X. M., Han, T., Cai, Y. X., Qian, B., Shen, Y. S., Zhang, H. Y., Wu, J. S., He, J., Chen, X. X., Guo, D. B., Zhong, H. T., Li, X., Zhang, L., Luo, X. M., Li, W. G., Lin, Y. C., & Lin, Z. N. (2025). MALAT1 promotes malignancy of HBV-related hepatocellular carcinoma by regulating IGF2BP3-mediated nuclear-cytoplasmic shuttling. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.112133

Vancouver

Du ZB, Wu XM, Han T, Cai YX, Qian B, Shen YS, et al. MALAT1 promotes malignancy of HBV-related hepatocellular carcinoma by regulating IGF2BP3-mediated nuclear-cytoplasmic shuttling. International Journal of Biological Sciences. 2025. doi:10.7150/ijbs.112133

BibTeX
@article{Du2025,
  author = {Du, Ze-Bang and Wu, Xin-Mou and Han, Tun and Cai, Yu-Xin and Qian, Bo and Shen, Yu-Shi and Zhang, Han-Yu and Wu, Jia-Shen and He, Jie and Chen, Xiao-Xuan and Guo, Dong-Bei and Zhong, Hang-Tian and Li, Xiong and Zhang, Lei and Luo, Xiao-Ming and Li, Wen-Gang and Lin, Yu-Chun and Lin, Zhong-Ning},
  title = {MALAT1 promotes malignancy of HBV-related hepatocellular carcinoma by regulating IGF2BP3-mediated nuclear-cytoplasmic shuttling},
  journal = {International Journal of Biological Sciences},
  year = {2025},
  doi = {10.7150/ijbs.112133}
}
Kostenlos starten →